| Literature DB >> 17824157 |
M Johanna Kaartinen1, Sophie Cuvelliez, Line Brouillard, Yves Rondenay, Jean Jacques Kona-Boun, Eric Troncy.
Abstract
This survey evaluates early perceptions about the use of medetomidine and atipamezole among veterinary practitioners in Quebec in 2002. Response rate was 23.5%; 71.1% of the practitioners did not use these products because of lack of information (69.3%), unavailability of the drugs in the practice (23.3%), or other reasons (7.3%), including concerns about the safety of alpha-2 agonists. Most veterinarians who used these products (70.4%) used them only rarely. Sedation by medetomidine was qualified as good (44.2%) or excellent (36%), and analgesia as good (46.5%) or average (32.7%). Waking up after atipamezole was qualified as good (47.5%) or excellent (40.9%). These perceptions indicate an opportunity for wider use of the products in veterinary practice. With more education and experience, practitioners could find medetomidine hydrochloride alone or in combination with an opioid useful for sedation, analgesia, and premedication for healthy animals. Reversal with atipamezole hydrochloride is considered effective, when residual sedation is undesirable.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17824157 PMCID: PMC1899846
Source DB: PubMed Journal: Can Vet J ISSN: 0008-5286 Impact factor: 1.008